Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

SmartVascular™ Test: Revolutionizing Vascular Risk Assessment Nationwide Provided by GlobeNewswire Jun 11, 2025, 6:21:05 PM. IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) ...

MorningStar Laboratories, LLC., (“MSL” or “the Company”), is a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce its expansion in the Midwest with ...

IRVINE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly ...

Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

MorningStar Laboratories, LLC ('MSL” or 'the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, proudly announces its SmartVascular Dx™ (SVDx) test ...

SmartVascular Dx™ Test: Enhancing Vascular Care in the Midwest Provided by GlobeNewswire Jun 25, 2025, 10:00:00 AM. IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

UCLA researchers found that two proteins doctors use to check for heart damage can also predict cancer years before symptoms ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia and demonstrated that targeting this process with a repurposed drug can ...